48Hour Discovery proud to sponsor the Canadian Glycomics Symposium 2018

EDMONTON (April 17 2018)–48Hour Discovery Inc. (48HD) is pleased to announce a sponsorship with the Canadian Glycomics Network (GlycoNet) to support the Canadian Glycomics Symposium 2018. The Symposium affords an exciting opportunity to glimpse the frontiers of knowledge in the emerging field of glycomics. This annual Symposium welcomes more than 200 researchers, trainees, and stakeholders in the fields of glycomics, biotechnology, and pharmaceuticals. The Symposium will feature presentations from notable national and international experts in carbohydrate science, as well as an open forum for young scientists to highlight their research. “We are thrilled to be a sponsor for the Symposium…

View article


Join Us for an Inside Look of our Technology

Join us for an exclusive tour of our molecular discovery platform. This half day workshop will take you through our exciting new technology and will involve hands-on experiments and real-time data analysis. The workshop will describe how you can leverage our molecular discovery pipeline for your own research endeavors. Purchase tickets here!

View article


48Hour Discovery Enters into Agreement with TumorGenesis

Edmonton-based start-up to develop personalized cancer therapy models: EDMONTON (March 29, 2018)–48Hour Discovery Inc. (48HD) announced today that they have signed an agreement with Precision Therapeutics Inc. (NASDAQ:AIPT) and its wholly owned subsidiary, TumorGenesis Inc. 48HD will grant access to its patented molecular discovery technology, enabling TumorGenesis Inc. to develop precision cancer therapy models. 48HD uses genetic encoding of small molecule display libraries for rapid discovery of novel molecular interactions. 48HD will apply the technology to discover patient-specific biomolecules for the development of individualized health care solutions. “We are excited to be a part of this cutting-edge technology enterprise for…

View article


GlycoNet Agreement with 48Hour Discovery

“We are extremely pleased to see a core service being commercialized… Supporting 48Hour Discovery fits with our strategic goals of spurring job creation and fostering start-up success in Canada.” said Dr. Todd Lowary, GlycoNet Scientific Director. To see full article, click here

View article


Highlight of 48Hour Discovery in the Edmonton Journal

Our company was recently highlighted in the Edmonton Journal: Edmonton startup wants to put Alberta at epicentre of molecular discoveries A University of Alberta biotechnology spinoff wants to put Edmonton at the epicentre of molecular discoveries by creating an immense searchable database that could speed up and drive down the cost of research and development. To read the full article, click here.  

View article